Logo image of ARA

American Renal Associates (ARA) Stock Price, Quote, News and Overview

NYSE:ARA - New York Stock Exchange, Inc. -

11.52  +0.02 (+0.17%)

ARA Quote, Performance and Key Statistics

American Renal Associates

NYSE:ARA (1/25/2021, 8:04:00 PM)

11.52

+0.02 (+0.17%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High11.98
52 Week Low5.57
Market Cap397.94M
Shares34.54M
Float11.64M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


ARA short term performance overview.The bars show the price performance of ARA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

ARA long term performance overview.The bars show the price performance of ARA in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of ARA is 11.52 null. In the past month the price increased by 0.61%. In the past year, price increased by 26.87%.

American Renal Associates / ARA Daily stock chart

About ARA

Company Profile

American Renal Associates Holdings, Inc. is a provider of dialysis services primarily in the United States. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. American Renal Associates Holdings, Inc. is based in Beverly, Massachusetts.

Company Info

American Renal Associates

500 CUMMINGS CENTER SUITE 6550

BEVERLY MA 01915

CEO: Joseph A. Carlucci

Phone: 978-922-3080

American Renal Associates / ARA FAQ

What is the stock price of American Renal Associates today?

The current stock price of ARA is 11.52 null. The price increased by 0.17% in the last trading session.


What is the ticker symbol for American Renal Associates stock?

The exchange symbol of American Renal Associates is ARA and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is ARA stock listed?

ARA stock is listed on the New York Stock Exchange, Inc. exchange.


What is American Renal Associates worth?

American Renal Associates (ARA) has a market capitalization of 397.94M null. This makes ARA a Small Cap stock.


What are the support and resistance levels for American Renal Associates (ARA) stock?

American Renal Associates (ARA) has a support level at 11.5 and a resistance level at 11.53. Check the full technical report for a detailed analysis of ARA support and resistance levels.


Should I buy American Renal Associates (ARA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does American Renal Associates (ARA) stock pay dividends?

ARA does not pay a dividend.


What is the Price/Earnings (PE) ratio of American Renal Associates (ARA)?

American Renal Associates (ARA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).


ARA Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ARA. When comparing the yearly performance of all stocks, ARA turns out to be only a medium performer in the overall market: it outperformed 50.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ARA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ARA. Both the profitability and financial health of ARA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARA Financial Highlights

Over the last trailing twelve months ARA reported a non-GAAP Earnings per Share(EPS) of -0.10999999999999999. The EPS decreased by -57.38% compared to the year before.


Industry RankSector Rank
PM (TTM) -1.11%
ROA -0.78%
ROE N/A
Debt/Equity 7.54
Chartmill High Growth Momentum
EPS Q2Q%-124.24%
Sales Q2Q%-0.82%
EPS 1Y (TTM)-57.38%
Revenue 1Y (TTM)-1.23%

ARA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to ARA. The Buy consensus is the average rating of analysts ratings from 2 analysts.


Ownership
Inst Owners0.01%
Ins Owners1.04%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price TargetN/A
EPS Next Y-142.31%
Revenue Next YearN/A